Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
Hovione today announced that it plans to host and operate a commercial-scale continuous manufacturing facility as part of an agreement with Vertex Pharmaceuticals
Manufacturing Chemist, 3 May 2023
Commitment to partnership and joint innovation for cell and gene therapies
Hovione´s pragmatic approach to bridging science with manufacturing is now being leveraged for continuous tableting and it is the key to ultimately providing high quality medicines and the success of your drug product.
Hovione won the 2023 CDMO Leadership Award across all six categories across all three groups of respondents
Hovione, the specialist integrated CDMO, just announced an expansion of its nasal drug delivery capabilities with the addition of a family of innovative nasal powder delivery devices developed in partnership with IDC.
CheManager, 20 October 2020
Silicon Republic, October 2, 2020
This expansion in New Jersey will create up to 100 jobs over the next few years is part of a global expansion strategy
‘One Site Shop’ expands to respond to growing demands
Google Chrome
Safari
Firefox
Edge